Nitazoxanide for persistent diarrhoea in Zambian acquired immune deficiency syndrome patients: A randomized-controlled trial

Alimentary Pharmacology and Therapeutics

Volumn 21, Issue 6, 2005, Pages 757-763

  Zulu, I ^a,d   Kelly, P ^a,b   Njobvu, L ^a   Sianongo, S ^a   Kaonga, K ^a   McDonald, V ^b   Farthing, M ^c   Pollok, R ^c  

^a UNIVERSITY OF ZAMBIA   (Zambia)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY TEACHING HOSPITAL   (Zambia)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; NITAZOXANIDE; PLACEBO;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BACTERIAL VIRULENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTESTINE INFECTION; LIVER FUNCTION TEST; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PARASITOLOGY; PRIORITY JOURNAL; PROTOZOAL INFECTION; RANDOMIZED CONTROLLED TRIAL; SEROPREVALENCE; ZAMBIA;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADMINISTRATION, ORAL; ADULT; ANTIPARASITIC AGENTS; BACTERIAL INFECTIONS; CD4 LYMPHOCYTE COUNT; CHRONIC DISEASE; DIARRHEA; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTESTINAL DISEASES, PARASITIC; MALE; THIAZOLES;

EID: 16344363049     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02394.x     Document Type: Article

References (21)

1. Central Statistical Office [Zambia]. Central Board of Health [Zambia], and ORC Macro. Zambia Demographic and Health Survey 2001-2002. Calverton, Maryland. USA: Central Statistical Office, Central Board of Health and ORC Macro, 2003.
2. Brink AK, Mahe C, Watera C, et al. Diarrhoea, CD4 counts and enteric infections in a community-based cohort of HIV-infected adults in Uganda. J Infect 2002: 45: 99-106.
3. Colebunders R, Francis H, Mann JM, et al. Persistent diarrhea, strongly associated with HIV infection in Kinshasa, Zaire. Am J Gastroenterol 1987; 82: 859-64.
4. Gassama A, Sow PS, Fall F, et al. Ordinary and opportunistic enteropathogens associated with diarrhoea in Senegalese adults in relation to human immunodeficiency virus serostatus. Int J Infect Dis 2001; 5: 192-8.
5. Kelly P, Baboo KS, Woolf M, Ngwenya B, Luo N, Farthing MJG. Prevalence and aetiology of persistent diarrhoea in adults in urban Zambia. Acta Trop 1996; 61: 183-90.
6. Mwachari C, Batchelor BIF, Paul J, Waiyaki PG, Gilks CF, Chronic diarrhoea among HIV-infected adult patients in Nairobi, Kenya. J Infect 1998; 37: 48.
7. Gumbo T, Sarbah S, Gangaidzo IT, et al. Intestinal parasites in patients with diarrhea and HIV infection in Zimbabwe. AIDS 1999; 13: 819-21.
8. Mwansa J, Mutela K, Zulu I, Amadi B, Kelly P. Antimicrobial sensitivity in enterobacteria from AIDS patients, Zambia. Emerg Infect Dis 2002; 8: 92-3. Erratum in: Emerg Infect Dis 2002; 8: 540.
9. Mwansa J, Mutela K, Zulu I, Amadi B, Kelly P. Antimicrobial sensitivity in enterobacteria from AIDS patients, Zambia. Emerg Infect Dis 2002; 8: 92-3. Erratum in: Emerg Infect Dis 2002; 8: 540.
10. Anglaret X, Chene G, Attia A, et al. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1 infected adults in Abidjan, Cote d'Ivoire: a randomised trial. Lancet 1999; 353: 1463-8.
11. Miao YM, Awad-El-Kariem FM, Gazzard BG. Opportunistic protozoan diarrhoea. J HIV Ther 2002; 7: 17-20.
12. Pape JW, Verdier R-I, Johnson WD. Treatment and prophylaxis of Isospora belli infection in patients with the acquired immunodeficiency syndrome. N Engl J Med 1989; 32: 1044-77.
13. Hewitt RG, Yiannoutsos CT, Higgs ES, et al. Paromomycin: no more effective than placebo for the treatment of cryptosporidiosis in patients with advanced HIV infection. AIDS Clinical Trial Group. Clin Infect Dis 2000; 31: 1084-92.
14. Kelly P, Lungu F, Keane E, et al. Albendazole chemotherapy for treatment of diarrhoea in patients with AIDS in Zambia: a randomised double-blind controlled trial. BMJ 1996; 312: 1187-91.
15. Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH. The use of the nitrogen mustards in the palliative treatment of carcinoma. Cancer 1948; 1: 634-56.
16. Zulu I, Veitch A, Sianongo S. et al. Albendazole chemotherapy for AEDS-related diarrhoea in Zambia - clinical, parasitological and mucosal responses. Aliment Pharmacol Ther 2002; 16: 595-601.
17. Rossignol JF, Ayoub A, Ayers MS. Treatment of diarrhoea caused by Cryptosporidium parvum: a prospective randomised double-blind placebo-controlled study of nitazoxanide. J Infect Dis 2001; 184: 103-6.
18. Rossignol JF, Hidalgo H, Feregrino M, et al. A double-'blind' placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhea in AIDS patients in Mexico. Trans R Soc Trop Med Hyg 1998; 92: 663-6.
19. Amadi B, Mwiya M, Musuku J, et al. Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet 2002; 360: 1375-80.
20. Kelly P, Musonda R, Kafwembe E, Kaetano L, Keane E, Farthing MJG. Micronutrient supplementation for the AIDS diarrhoea-wasting syndrome in Zambia: a randomised controlled trial. AIDS 1999; 13: 495-500.
21. Weber R, Bryan RT, Bishop HS, Wahlquist SP, Sullivan JJ, Juranek DD. Threshold of detection of Cryptosporidium oocysts in human stool specimens: evidence for low sensitivity of current diagnostic methods. J Clin Microbiol 1991; 29: 1323-7.